Vasomotor rhinitis. Vasomotor rhinitis
Conditions
Interventions
Intervention 1: Intervention group: Take intra nasal conjugated estrogen ointment daily(50 mg containing 300 micrograms of estrogen) for 3 months. Intervention 2: Control group: They were treated with
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Menopausal women 12 months after their last menstrual bleeding Symptoms of nasal congestion (feeling of fullness in the nose, feeling of discomfort and heaviness in the nose - feeling of reduced airflow in the nose, loss of smell or mouth breathing)
Exclusion criteria
Exclusion criteria: Use of drugs affecting the nasal airway and nasal mucosa (systemic and local) Systemic underlying diseases Previous history of rhinoplasty and sinus surgery Obstructive symptoms before menopause Presence of known sinonasal diseases, including pulpitis, chronic sinusitis, sinonasal tumors (both benign and malignant) Smoking and inhaled drugs Occupational exposure to chemical stimulants and its history Patients w?ho did not have the proper cooperation for rhinomanometry, endoscopy and the use of drugs and follow-up Patients for whom estrogen use is contraindicated
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of estrogen on rhinitis. Timepoint: Three months after treatment. Method of measurement: Rhinomanometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahboobe Asadi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed